Roivant Sciences is a biopharmaceutical company focused on advancing innovative treatments for various diseases through a unique model that emphasizes the development of underutilized compounds and technologies

The company aims to accelerate the drug development process by leveraging a network of subsidiaries, each dedicated to specific therapeutic areas, including neurology, immunology, and rare diseases. By fostering collaboration and employing a data-driven approach, Roivant seeks to bring effective therapies to patients more efficiently and enhance the overall landscape of healthcare.